tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market
BMRN
BioMarin Pharmaceutical
RESEARCH TOOLSreports

BioMarin Pharmaceutical (BMRN) Stock News & Sentiment

Compare
2,375 Followers
Balanced View on BioMarin’s Amicus Acquisition: Strategic Rare-Disease Upside Versus Near-Term Leverage and Earnings Dilution Supports Hold Rating
Premium
Ratings
Balanced View on BioMarin’s Amicus Acquisition: Strategic Rare-Disease Upside Versus Near-Term Leverage and Earnings Dilution Supports Hold Rating
3d ago
BMRN
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
3d ago
BB
AMD
BioMarin’s Amicus Acquisition: Leveraging Rare-Disease Assets and IP Extension to Drive Blockbuster Growth and Support a Buy Rating
Premium
Ratings
BioMarin’s Amicus Acquisition: Leveraging Rare-Disease Assets and IP Extension to Drive Blockbuster Growth and Support a Buy Rating
3d ago
BMRN
BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
Premium
Market News
BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
3d ago
BMRN
FOLD
BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
Premium
Company Announcements
BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
3d ago
8K
BMRN
BioMarin Names New Chief Accounting Officer
Premium
Company Announcements
BioMarin Names New Chief Accounting Officer
5d ago
8K
BMRN
Biomarin’s Acquisition Strategy: Navigating Risks and Challenges for Future Growth
Premium
Company Announcements
Biomarin’s Acquisition Strategy: Navigating Risks and Challenges for Future Growth
2M ago
BMRN
More BMRN News >

BMRN News on the Web

BioMarin Stock Surges Nearly 20% After $4.8 Bln Amicus Acquisition News
rttnews
Neutral
William Blair views BioMarin acquisition of Amicus as 'strategic fit'
The Fly
Neutral
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
TipRanks News
Neutral
BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
TipRanks News
Neutral
BioMarin To Acquire Amicus Therapeutics For Around $4.8 Bln
rttnews
Neutral
BioMarin's $4.8 Billion Amicus Acquisition: Immediate Revenue Acceleration and Rare Disease Expansion Ahead
Market Chameleon
Neutral
BioMarin's $4.8B Amicus Acquisition Aims to Boost Rare Disease Leadership and Accelerate Revenue Growth
Market Chameleon
Neutral
Why BioMarin Pharmaceutical Inc.’s (BMRN) Stock Is Up 14.13%
AAII
Neutral

News Score - Last 7 Days

Neutral
BMRN
Sector Average
Media Buzz
This Week9 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BMRN’s Media Buzz Sentiment?
9 articles about BMRN were published this week. In an average week, 3 articles are published.
    What is BMRN’s weekly average amount of articles?
    In an average week, 3 articles about BMRN are published.
      What is BMRN’s News Sentiment?
      50% of articles about BMRN were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        TXG10x Genomics
        ANIPANI Pharmaceuticals
        HIKHikma Pharmaceuticals
        PCSAProcessa Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week